- Published on:
Beijing, Mar 18 (Prensa Latina) Five Chinese pharma companies have signed an agreement with a UN-backed organization to produce a generic version of Pfizer's antiviral Nirmatrelvir, used to treat Covid-19 patients, local press reported on Friday.







